<http://webisa.webdatacommons.org/380154112>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<prnewswire.com> .
<http://webisa.webdatacommons.org/prov/398463993>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/380154112> .
<http://webisa.webdatacommons.org/prov/160225812>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/380154112> .
<http://webisa.webdatacommons.org/380154112>	<http://www.w3.org/ns/prov#value>	"SACRAMENTO, Calif., July 15, 2013 /PRNewswire/ -- SynGen Inc., a company focused on the development and commercialization of medical systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and other tissues, announced today that it has been granted FDA 510(k) clearance to market its three related products to process cord blood: SynGenXTM-1000 System" .
<http://webisa.webdatacommons.org/380154112>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .